Employing nanotechnology to reduce cancer metastasis

Michael King is Professor of Biomedical Engineering at Cornell. The King lab is currently testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging. This work will uncover new therapeutic targets designed to prevent metastasis.

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
You have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today. Subscribe for unlimited access.
Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×